EP3367875A1 - Lumen traveling device - Google Patents
Lumen traveling deviceInfo
- Publication number
- EP3367875A1 EP3367875A1 EP16860658.0A EP16860658A EP3367875A1 EP 3367875 A1 EP3367875 A1 EP 3367875A1 EP 16860658 A EP16860658 A EP 16860658A EP 3367875 A1 EP3367875 A1 EP 3367875A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- traveling device
- lumen
- lumen traveling
- sensor
- display
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000033001 locomotion Effects 0.000 claims description 55
- 238000003384 imaging method Methods 0.000 claims description 23
- 210000004204 blood vessel Anatomy 0.000 claims description 14
- 239000002775 capsule Substances 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 11
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 11
- 229940124597 therapeutic agent Drugs 0.000 claims description 11
- 230000003287 optical effect Effects 0.000 claims description 10
- 210000001635 urinary tract Anatomy 0.000 claims description 8
- 238000001574 biopsy Methods 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 210000005000 reproductive tract Anatomy 0.000 claims description 7
- 230000004044 response Effects 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 238000003306 harvesting Methods 0.000 claims description 4
- 239000000446 fuel Substances 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 239000002551 biofuel Substances 0.000 claims description 2
- 238000006073 displacement reaction Methods 0.000 claims 2
- 210000000613 ear canal Anatomy 0.000 claims 2
- 239000011263 electroactive material Substances 0.000 claims 2
- 239000012781 shape memory material Substances 0.000 claims 2
- 210000003954 umbilical cord Anatomy 0.000 claims 2
- 230000006378 damage Effects 0.000 claims 1
- 230000002123 temporal effect Effects 0.000 claims 1
- 239000000306 component Substances 0.000 description 46
- 206010028980 Neoplasm Diseases 0.000 description 27
- 238000000034 method Methods 0.000 description 26
- 238000012545 processing Methods 0.000 description 21
- 230000006870 function Effects 0.000 description 17
- 230000008569 process Effects 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 14
- 238000004891 communication Methods 0.000 description 14
- 238000004590 computer program Methods 0.000 description 14
- 230000007246 mechanism Effects 0.000 description 14
- 230000005540 biological transmission Effects 0.000 description 11
- 238000005070 sampling Methods 0.000 description 11
- 206010061218 Inflammation Diseases 0.000 description 9
- 230000009471 action Effects 0.000 description 9
- 230000004054 inflammatory process Effects 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 230000003993 interaction Effects 0.000 description 8
- 230000003137 locomotive effect Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 238000002512 chemotherapy Methods 0.000 description 6
- 208000020816 lung neoplasm Diseases 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 210000005166 vasculature Anatomy 0.000 description 6
- 208000031481 Pathologic Constriction Diseases 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 208000037062 Polyps Diseases 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 208000034158 bleeding Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 201000005202 lung cancer Diseases 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 210000003101 oviduct Anatomy 0.000 description 4
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 4
- 238000012876 topography Methods 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 210000003708 urethra Anatomy 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- 101100234822 Caenorhabditis elegans ltd-1 gene Proteins 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 206010046996 Varicose vein Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000002591 computed tomography Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 208000027185 varicose disease Diseases 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 238000013528 artificial neural network Methods 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000002041 carbon nanotube Substances 0.000 description 2
- 229910021393 carbon nanotube Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000701 coagulant Substances 0.000 description 2
- 238000000205 computational method Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000009193 crawling Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920001746 electroactive polymer Polymers 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 208000037841 lung tumor Diseases 0.000 description 2
- 230000001926 lymphatic effect Effects 0.000 description 2
- 210000004995 male reproductive system Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- -1 poly(p-phenylene vinylene) Polymers 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 210000001177 vas deferen Anatomy 0.000 description 2
- 238000007879 vasectomy Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 206010059313 Anogenital warts Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 208000000907 Condylomata Acuminata Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 208000006994 Precancerous Conditions Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000002042 Silver nanowire Substances 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- SPAHBIMNXMGCMI-UHFFFAOYSA-N [Ga].[In] Chemical compound [Ga].[In] SPAHBIMNXMGCMI-UHFFFAOYSA-N 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000025009 anogenital human papillomavirus infection Diseases 0.000 description 1
- 201000004201 anogenital venereal wart Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000013473 artificial intelligence Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 239000012829 chemotherapy agent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 201000003511 ectopic pregnancy Diseases 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000006023 eutectic alloy Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 210000005224 forefinger Anatomy 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000003767 ileocecal valve Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000012905 input function Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003903 intestinal lesions Effects 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 229910001338 liquidmetal Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000553 poly(phenylenevinylene) Polymers 0.000 description 1
- 229920002098 polyfluorene Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000000513 principal component analysis Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000001141 propulsive effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000007674 radiofrequency ablation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000002463 transducing effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000009810 tubal ligation Methods 0.000 description 1
- 208000006685 tubal pregnancy Diseases 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/06—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor with illuminating arrangements
- A61B1/0661—Endoscope light sources
- A61B1/0684—Endoscope light sources using light emitting diodes [LED]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00002—Operational features of endoscopes
- A61B1/00004—Operational features of endoscopes characterised by electronic signal processing
- A61B1/00009—Operational features of endoscopes characterised by electronic signal processing of image signals during a use of endoscope
- A61B1/000094—Operational features of endoscopes characterised by electronic signal processing of image signals during a use of endoscope extracting biological structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
- A61B1/041—Capsule endoscopes for imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/0233—Pointed or sharp biopsy instruments
- A61B10/0266—Pointed or sharp biopsy instruments means for severing sample
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/04—Endoscopic instruments, e.g. catheter-type instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/073—Intestinal transmitters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00002—Operational features of endoscopes
- A61B1/00011—Operational features of endoscopes characterised by signal transmission
- A61B1/00016—Operational features of endoscopes characterised by signal transmission using wireless means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00147—Holding or positioning arrangements
- A61B1/00158—Holding or positioning arrangements using magnetic field
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/267—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the respiratory tract, e.g. laryngoscopes, bronchoscopes
- A61B1/2676—Bronchoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/31—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the rectum, e.g. proctoscopes, sigmoidoscopes, colonoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/06—Biopsy forceps, e.g. with cup-shaped jaws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B2010/0216—Sampling brushes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
- A61B2560/0219—Operational features of power management of power generation or supply of externally powered implanted units
Definitions
- FIG. 1 A is a partial view of a device and system described herein.
- FIG. 1 B is a partial view of a device and system described herein.
- FIG. 1C is a partial view of a device and system described herein.
- FIG. 2A is a partial view of a device and system described herein.
- FIG. 2B is a partial view of a device and system described herein.
- FIG. 3A is a partial view of a device and system described herein.
- FIG. 3B is a partial view of a device and system described herein.
- FIG. 4 is a partial view of a component of the device and system described herein.
- FIG. 5 is a partial view of a component of the device and system described herein.
- a lumen traveling device and system are adapted for traveling within a natural or artificial (e.g. , catheter, shunt) lumen of a subject's body.
- the lumen traveling device is at least one of disposable, biodegradable, or bioresorbable, in part or in total.
- the lumen traveling device is sized and shaped according to specifications of the particular lumen it is designed to travel within, or the specifications of the function or operation of the lumen traveling device.
- the lumen traveling device is of a fixed size or shape.
- the lumen traveling device is flexible.
- the lumen traveling device is spheroid, cylindrical, pyramidal, cuboid, or any combination thereof.
- the lumen traveling device is sized and shaped for ingestion. In an embodiment, the lumen traveling device is sized and shaped for surgical introduction or implantation into a lumen. In an embodiment, the lumen traveling device is sized and shaped for injection into a lumen or an organ having lumen or duct. In an embodiment, the lumen traveling device is sized and shaped for introduction into a lumen via a catheter or cannula. In an embodiment, the lumen traveling device is sized and shaped for injection into at least a portion of an alimentary canal, a blood vessel, a respiratory tract, a urinary tract, genital tract, a duct of an organ, or the like. In an embodiment, the lumen traveling device comprises all or part of a micro-robot (e.g., microbot). In an embodiment, the lumen traveling device includes all or part of a capsule endoscope.
- a micro-robot e.g., microbot
- the lumen traveling device is
- the lumen traveling device is approximately 20 mm or less, approximately 10 mm or less, approximately 5 mm or less in width or height (i.e. diameter).
- the lumen traveling device includes layers of several materials. In an embodiment, at least one layer of the lumen traveling device includes a permeable or semi-permeable membrane. In an embodiment, the lumen traveling device includes at least one mesh surface. In an embodiment, the lumen traveling device includes expandable or contractible materials, for example metal or plastic components that are capable of being altered in size or shape. In an embodiment, the lumen traveling device includes a shape memory alloy or electroactive polymer. In an embodiment, at least one component of the lumen traveling device includes a metal, ceramic, paper, polymer (plastic, silicone, etc.), silk, or other suitable biocompatible materials. In an embodiment, the lumen traveling device can be manufactured according to various techniques, including 3-D printing, self-assembly, rapid-prototyping, die-cutting, extrusion, injection molding, or the like.
- the lumen traveling device and system includes at least one sensor.
- the sensor is used to determine location of the lumen traveling device (e.g., based on the parameters sensed at a particular location of a lumen).
- at least one sensor is used to determine at least one physiological parameter that may be used for determining a medical treatment, a change in treatment, or a diagnosis of the subject.
- the senor includes, for example, at least one of a pressure sensor, temperature sensor, flow sensor, viscosity sensor, shear sensor, pH sensor, gas sensor, chemical sensor, optical sensor, acoustic sensor, biosensor, electrical sensor, magnetic sensor, clock, or timer.
- a pressure sensor for example, at least one of a pressure sensor, temperature sensor, flow sensor, viscosity sensor, shear sensor, pH sensor, gas sensor, chemical sensor, optical sensor, acoustic sensor, biosensor, electrical sensor, magnetic sensor, clock, or timer.
- the senor detects a physiological condition, such as level of a blood component (e.g., pH, hormone, vitamin or mineral, cholesterol, oxygen, bilirubin, hemoglobin, etc.), presence or number of a cell type (red blood cells, white blood cells, immune cells, malignant cells, necrotic cells, etc.), immune function (e.g., inflammation, bleeding, infection, auto-immunity, etc.), microbiome (e.g., levels of healthy or unhealthy microorganisms, etc.), blood pressure, or other condition.
- a physiological condition such as level of a blood component (e.g., pH, hormone, vitamin or mineral, cholesterol, oxygen, bilirubin, hemoglobin, etc.), presence or number of a cell type (red blood cells, white blood cells, immune cells, malignant cells, necrotic cells, etc.), immune function (e.g., inflammation, bleeding, infection, auto-immunity, etc.), microbiome (e.g., levels of healthy or unhealthy microorgan
- the senor detects lumen surface integrity (e.g., presence of a lesion, tumor, ulcer, fissure, wound, etc.), for example associated with an autoimmune disorder (e.g., Crohn's disease lesion), cancer or precancerous condition (e.g., a tumor or polyp), or vascular disorder (e.g., gastrointestinal bleeding or varices).
- the sensor detects an analyte, for example, a physiological analyte.
- the sensor detects a tag (e.g., a radiographic or colorimetric agent that binds to cells or components of cells or binds to other components of biological fluids, such as hemoglobin, insulin, etc. and that can be utilized to detect or monitor a specific medical condition or disease).
- the lumen traveling device and/or system includes at least one power source.
- the power source may be located on the surface of the lumen traveling device, inside a compartment of the lumen traveling device, or other location.
- the lumen traveling device and/or system includes at least one battery, microbattery, thin-film battery, or nuclear battery.
- the lumen traveling device and/or system includes at least one fuel cell or biofuel cell, for example at least one enzymatic, microbial, or photosynthetic fuel cell.
- the power source includes a nanogenerator (e.g. DNA, piezoelectric wires, or other tensile material).
- the power source includes at least one of an optical power source, acoustic receiver, electromagnetic receiver, or electrical power source.
- the power source is connected to the lumen traveling device and/or system through a cable or physical link.
- the lumen traveling device and/or system is wireless.
- the lumen traveling device is located within the subject's body by way of various sensors, as described herein, for example by query sensing (reflected and time-of -flight) or passive sensing (LTD emitting signal) between the LTD and externally alignable display and control device (EADCD).
- EADCD externally alignable display and control device
- a specific electromagnetic signal e.g. , RF or magnetic
- the LTD is aligned with the strongest signal, indicating alignment with the EADCD.
- the time-of -flight value is utilized to determine the location of the LTD from the
- the EADCD has more than one receiver at different locations on the device, and a comparison of the strength of the signal at each receiver indicates which receiver the LTD is closer to, and allows for locational determination.
- the lumen traveling device and/or system includes at least one component for harvesting energy.
- the lumen traveling device and/or system includes at least one component for harvesting energy from the body, for example kinetic energy (e.g. , from fluid flow or peristalsis) or thermal energy, and transducing the energy to power.
- the lumen traveling device and/or system includes at least one component for harvesting energy from a source external to the body, for example infrared radiation from a dedicated source.
- the lumen traveling device or system includes at least one component for wireless energy transfer.
- the lumen traveling device includes at least one energy receiver configured to receive power from at least one external energy transmitter. For example, acoustic energy, electrical energy, or optical energy can be transmitted to the lumen traveling device from another location.
- ultrasonic energy or microwave energy can be beamed to a receiver and converted into a current.
- the lumen traveling device includes at least one capacitive coupling link. In an embodiment, the lumen traveling device includes at least one inductive coupling link. In an embodiment, the lumen traveling device can include at least one receiving coil configured to receive energy from an external transmitting coil. In an embodiment, the lumen traveling device includes multiple receiving coils, for example in a topography and/or configuration conducive to receiving power.
- the other location includes, for example, another external device that includes, for example, at least one power transmitter or power receiver, and associated structures for at least one of using, storing, or retransmitting power.
- a remote device for the lumen traveling device may also include power transmitters or power receivers.
- the lumen traveling device and system include control circuitry that may be part of the internal device components, and/or part of the system that is external to the lumen traveling device itself (e.g., a remote control or other computing device).
- control circuitry is part of the internal device components, and/or part of the system that is external to the lumen traveling device itself (e.g., a remote control or other computing device).
- the control circuitry is
- control circuitry is stored as or implemented as non- transitory machine readable machinery.
- data storage or usage can include implementation as non-transitory machine readable machinery.
- the lumen traveling device and system is configured for movement within a natural or artificial lumen of a subject's body.
- the lumen traveling device and system is configured for passive movement; for example, the device is shaped to promote movement with natural flow or lumen movements, e.g. , peristalsis.
- the lumen traveling device and system is configured to utilize an external field, such as a magnetic field, to compel movement of the lumen traveling device, for example directly, as by a magnetic field exerting a force on the device, or indirectly, as in influencing an onboard controller.
- the lumen traveling device and system is configured for active movement within a natural or artificial lumen of a subject's body and includes means for locomotion.
- the lumen traveling device may have a rolling motion, a crawling or walking motion (e.g., with leg-like protrusions), a swimming motion, an inchworm-like motion, a stick and slip motion, propelling motion, or a ciliated motion.
- the lumen traveling device and system is configured for movement within a natural or artificial lumen of a subject's body according to direction provided by the controller in response to the one or more various sensors.
- the lumen traveling device includes as a means for locomotion, a propulsion system.
- the lumen traveling device includes a magnetohydrodynamic propulsion system that propels the lumen traveling device in a determined direction by ejecting a fluid jet.
- the lumen traveling device includes an inertia-based propulsion system, for example an impulse-driven micromechanism having as a moving mass a permanent magnet that is driven by magnetic force achieved by applying a current to a coil.
- the lumen traveling device includes a propeller.
- a propeller can include a rotor driven by an electric or magnetic motor or actuator.
- the lumen traveling device and system configured for movement according to direction includes a rudder, for example under control of a controller, to steer the device in a particular direction.
- the lumen traveling device includes one or more appendages that function as paddles to propel the device, for example, through a fluid.
- the lumen traveling device can include a linear actuator to drive paddle appendages in a manner so as to advance the device; combinations of paddles and their actuation can be used to induce movement in a particular direction.
- the lumen traveling device can include internal permanent magnets configured to move a number of polymeric flaps or a single tail that provide thrust through the fluid.
- the lumen traveling device can include a single tail of an electroactive polymer configured to provide thrust and direction.
- the lumen traveling device includes at least one locomotive mechanism configured to touch, grasp, grip, or otherwise engage the wall (e.g. surface) of a natural or artificial lumen of a subject's body.
- the lumen traveling device includes at least one inchworm-like movement mechanism, in which at least a portion of the lumen traveling device intermittently engages and disengages from the wall of the lumen in a slip-and- stick fashion thereby traversing a distance.
- the lumen traveling device includes a vibratory locomotive mechanism, for example a mechanism inducing forced bending vibrations of continua of the lumen traveling device driven by actuators such as piezoelectric bending actuators.
- the locomotion direction of the lumen traveling device can be controlled by the excitation frequencies of the actuation element.
- the lumen traveling device includes a sectional design, and each section is driven separately to engage or disengage the wall.
- the lumen traveling device can include at least one actuator that drives the movement of the lumen traveling device and the engagement of the wall.
- the lumen traveling device might include two-way linear actuators using a pair of springs made from a shape memory alloy.
- the lumen traveling device might include a piezoelectric microactuator.
- the lumen traveling device might include a micromotor.
- the lumen traveling device is jointed between sections of the lumen traveling device, and one or more actuators drive each section, for example, in a worm-like fashion.
- the lumen traveling device includes an expandable bellow, for example, a pneumatic bellows that provides the locomotive mechanism.
- the lumen traveling device includes surface-engaging protrusions, microprotrusions, adhesive micropilli, or clamps.
- the lumen traveling device includes radially expandable portions that expand to engage and disengage the inner surface lumen of the lumen.
- the lumen traveling device includes as a locomotive means an impelling mechanism configured to engage the wall (e.g., surface) and provide locomotion to the device; for example, an impelling device might comprise one or more appendages, legs, or wheels, with or without adhesive aspects such as micropilli.
- an impelling device might comprise one or more appendages, legs, or wheels, with or without adhesive aspects such as micropilli.
- a number of mechanisms to actuate an impelling mechanism can be adapted for use with various embodiments described herein.
- actuators and motors can be used to drive impelling devices.
- actuators include piezoelectric, DC motors, electromagnetic, and electrostatic actuators.
- actuators can be formed from shape memory alloys or ionic polymer metal components.
- jointed appendages and legs can be actuated to propel the device forward in a walking or crawling motion.
- a meso-scale legged locomotion system can include a slot-follower mechanism driven via lead screw to provide propulsive force to a jointed leg.
- multiple jointed legs e.g. , of superelastic or other material, can be motivated to interact with the wall under control of a motor, e.g., a brushless minimotor.
- appendages or legs can be formed from shape memory alloy and driven by the application of current.
- appendages can act to engage the wall driven by rotational forces to provide locomotion.
- wheels can be driven by motors or other actuators.
- the lumen traveling device and system is configured to employ one or more impelling mechanisms in a manner to provide movement in a particular direction.
- to change direction e.g., as directed by a controller
- only a portion of multiple appendages (or legs or wheels) can be actuated, thereby moving a portion of the device so that the device heads in a new direction and allowing the device to be steered.
- the lumen traveling device and system includes means for stabilization within the lumen, e.g. , for maintaining orientation or position within the lumen.
- the lumen traveling device and system includes one or more masses that can be steadied by an external field, for example a pair of permanent magnets that can be steadied in a magnetic field.
- the lumen traveling device and system includes one or more gyroscope or one or more accelerometer.
- the lumen traveling device and system includes one or more self-expanding stabilizing devices such as appendages, balloons, or capsules. A self-expanding stabilizing device can further have functionality in expanding the lumen.
- the lumen traveling device and system includes at least one location sensor to determine localization and spatial information regarding the lumen traveling device, including its position in three-dimensional (3D) space, the distance it has travelled along the lumen, and the region of the lumen in which it is located.
- 3D three-dimensional
- the lumen traveling device and system includes an external device employing delivery of energy of one or more frequencies in the electromagnetic spectrum (e.g., radiowaves, microwaves, infrared, visible waves, ultraviolet waves, x rays, gamma rays) for tracking the lumen traveling device.
- the lumen traveling device and system includes an imaging device (for example a magnetic resonance imager, x-ray imager, gamma camera, or the like) able to detect and track the lumen traveling device, which may be carrying a tag, for example a radiographic agent or contrast agent.
- the lumen traveling device and system includes a location sensor that is an ultrasound imaging device.
- a location sensor that is an ultrasound imaging device.
- an ultrasound imager housed in or otherwise associated with the externally alignable display and control device can be configured to utilize time of flight (ToF) between transmission of signals and reception of reflected signals to track the lumen traveling device, while the lumen traveling device is within the threshold of the location sensor.
- the lumen traveling device is sensed when it is in the scanning plane, as determined by the location sensor.
- the lumen traveling device includes an ultrasound transducer that emits signals able to be received by one or more receivers, for example in the externally alignable display and control device or in an array of external receivers positioned on the body and in communication with the externally alignable display and control device.
- a method includes detecting at least one interaction of a lumen traveling device with a lumen of a subject by way of one or more sensors in or on a lumen traveling device; generating at least one sensed signal based on detection of the at least one interaction of the lumen traveling device with the lumen; determining if the sensed signal exceeds a threshold value for the at least one interaction; generating at least one communication signal based on the determination of whether the sensed signal exceeds the threshold value for the at least one interaction.
- determining if the sensed signal exceeds a threshold value for the at least one interaction includes comparing the sensed signal to a reference data indicative of the threshold value.
- the reference data is derived from at least one sensed signal, programmed by a user, or set while the device or system is in use.
- the interactions of the lumen traveling device with the lumen itself can be attributed more value, in that information is obtained from such interactions if a threshold is exceeded.
- the lumen traveling device determines whether, for example, the sample size or location or type is sufficient to obtain the desired information. If such a threshold is exceeded, then the sample is taken and evaluated to provide the information sought. If the threshold is not satisfied, then the sample will not be taken at that time or location or in that manner, for example, and instead will be taken in another place, time, or manner, etc. so that the threshold evaluation can be conducted again.
- the lumen traveling device and system includes a location sensor that employs magnetic tracking of the lumen traveling device.
- the lumen traveling device includes at least one permanent magnet that is trackable by a magnetic sensor (e.g., magnetoresistive sensor) associated with (e.g., a skin-mounted array in communication with) or housed in the externally alignable display and control device.
- a magnetoresistive sensor inside the lumen traveling device can measure the intensity of the external magnetic field generated by external energized coils.
- a high frequency magnetic field can be used
- the lumen traveling device and system includes a location sensor that employs inertial sensing to determine localization.
- the lumen traveling device and system includes one or more
- accelerometers which may function alone or in concert with an actuation field.
- the lumen traveling device and system includes a location sensor that utilizes radio frequency signals.
- the lumen traveling device and system can include at least one external sensor array that evaluates an RF signal (e.g., for frequency and strength) transmitted by a transmitter housed in the lumen travelling device. The system can utilize information from the array to estimate distance and triangulate the signal.
- the lumen traveling device can include an RFID tag.
- the lumen traveling device can include an RFID tag comprising a bidirectional, tridirectional, or
- the lumen traveling device and system includes one or more software algorithms, e.g., to address signal propagation and reception, as well as noise reduction, can be used to increase efficiency and accuracy.
- the lumen traveling device and system employs hardware and software to evaluate the phase difference of arrival at multiple frequencies of a signal to estimate the distance of the source to a receiver, together with linear least square estimation or other software algorithms.
- the lumen traveling device and system includes hardware and software to employ image comparisons to determine the position of the lumen traveling device.
- images e.g., moving picture experts group (MPEG)-7 images
- MPEG moving picture experts group
- Images can be classified by hardware and software of the system utilizing, for example, vector quantization, principal component analysis, and neural networks, and/or event boundary detection algorithms, e.g. , to identify topography, colors, elasticity, and the like.
- the lumen traveling device and system includes one or more location sensors that measure a distance.
- a lumen traveling device can include a protrusion, (e.g., a wheel) attached to a counter (e.g. , an odometer) that measures the distance the device has traveled, e.g. , along a lumen wall.
- a lumen traveling device can include a protrusion, (e.g. , a flap) attached to a counter that measures the distance the device has traveled based on, for example the duration, force, or intermittent pulse, of pressure e.g., from fluid flow. See figures for more details.
- the lumen traveling device and system is configured for anchoring, at least temporarily, to the side wall of a lumen.
- the lumen traveling device may include a wall-anchoring system with at least one of a hook, tether, peg, suction, spring, or adhesive.
- the lumen traveling device includes at least one reservoir containing one or more adhesives. See figures for more details.
- the lumen traveling device is configured for easy removal from the lumen. In an embodiment the lumen traveling device is removable as a whole. In an embodiment, the lumen traveling device is removable in portions, e.g. , after disintegration or degradation. In an embodiment, the lumen traveling device is configured for manual removal. In an embodiment, the lumen traveling device includes a tether, or other surface design, for removal through the introductory path. In an embodiment, a capsule endoscope used to image or treat the esophagus may include a tether for pulling the capsule back up through the mouth.
- all or part of a lumen traveling device introduced into a lumen via a needle or catheter can be configured for manual removal via needle, catheter, etc., and may include magnetic or other attractive features.
- all or part of the lumen traveling device is expelled via natural elimination.
- a capsule endoscope traversing the gut can be expelled through the anus via natural digestive elimination.
- all or part of a lumen traveling device can be expelled from a respiratory system via a cough.
- all or part of a lumen traveling device having been introduced into a portion of a urogenital system can be expelled via the urethra.
- biochemical remnants of a biodegradable lumen traveling device traveling in a blood stream can be eliminated via the liver.
- at least part of the lumen traveling device is disposable.
- at least part of the lumen traveling device is biodegradable, so no retrieval from the subject is required.
- the lumen traveling device includes at least one onboard instrument.
- the lumen traveling device includes one or more imaging devices.
- the lumen traveling device can include a camera, a CCD sensor, a CMOS sensor, a spectroscopic camera (e.g., one that sees cells underneath the surface layer of tissue), or the like.
- the lumen traveling device includes one or more biopsy tool.
- the lumen traveling device can include an aspiration tool, biopsy clip, biopsy punch, a curette, or the like.
- the lumen traveling device includes one or more deployment tool.
- the lumen traveling device can include a mechanism for deploying a surgical clip or staple to a treatment site in the lumen (e.g., to a varix).
- the lumen traveling device can include a mechanism for delivering a coil.
- the lumen traveling device includes a needle, for example to deliver a therapeutic agent directly to a treatment site on the lumen tissue.
- the lumen traveling device includes an energy emitter.
- the lumen traveling device can include a wire that delivers heat to cauterize a tissue.
- the lumen traveling device can include a thermal tool for ablating a tissue.
- the lumen traveling device can include an ultrasound emitter or the like.
- the lumen traveling device includes at least one sampling means, as described herein.
- the lumen traveling device includes a liquid capture device, for example a reservoir or adsorbent or absorbent material.
- sampling means are housed in leg-like protrusions that engage the lumen wall (e.g., nano or micro calipers 375
- the sampling means is able to obtain small samples of blood, tissue, cells (including, for example, microorganisms or components thereof), nucleic acids, proteins, etc. from the lumen of the subject.
- the lumen traveling device and system is configured to image or map a lumen. In an embodiment, the lumen traveling device and system is configured to provide treatment in a lumen. In an embodiment, the lumen traveling device is followed in the lumen by the externally alignable display and control device (EADCD) in real-time and spatial alignment. In an embodiment, the lumen traveling device can be directed to advance or return to a site in the lumen by the externally alignable display and control device in real-time, and further action by the lumen traveling device can be directed via the externally alignable display and control device.
- EADCD externally alignable display and control device
- the lumen traveling device and system is used to image, map, or provide treatment to a lumen that includes at least a portion of an alimentary canal, a blood vessel, a respiratory tract, a urinary tract, genital tract, a duct of an organ, or the like.
- a system includes a memory device wherein the memory device is configured to retrieve data associated with a specific location corresponding to a lumen reference path previously traveled by the lumen traveling device when queried.
- the data is not retrievable unless the EADCD is within a proximity threshold from where the LTD actually traveled in the lumen (e.g., the proximity threshold includes at least one of approximately one millimeter, approximately ten millimeters, approximately 100 millimeters, approximately one centimeter, or approximately ten centimeters from the actual path traveled in the lumen.
- the reference map is a predetermined pathway intended for the LTD to follow, while the reference path is a map of the actual path the LTD took as it traveled through a lumen.
- the reference path may not ideally follow the exact reference map of the lumen, but should be approximately the same.
- the LTD does not transmit data unless and until it enters a threshold range of a predetermined location (e.g., a specific location in the lumen such as a specific section of the intestinal tract of a subject). In this way, the LTD conserves power and can be manufactured with lightweight, thin battery power source.
- the LTD is
- the LTD is remote controllable to not transmit data until it reaches the predetermined target location.
- the LTD emits a location beacon or signal to verify its location as it travels through the lumen, only transmitting additional data about the condition of the lumen (e.g., biological tissue sampling, therapeutic agent delivery, etc.) until it reaches the predetermined target location.
- the lumen traveling device can be introduced into any portion of an alimentary canal, such as the esophagus, stomach, small intestine, large intestine, and the like, through ingestion or delivery (e.g. , by conventional endoscope or suppository).
- the lumen traveling device can be used to image some or all of the alimentary canal to look for anomalies such as but not limited to polyps, tumors, varices, bleeding, obstructions, inflammation, and the like.
- the lumen traveling device can be used to perform a treatment in the alimentary canal, such as treatment of a gastrointestinal bleed by delivering energy (e.g., thermal energy as in cauterizing or freezing or
- the lumen traveling device is followed in the alimentary canal by the externally alignable display and control device in real-time and spatial alignment.
- the lumen traveling device can be directed to advance or return to a site in the alimentary via the externally alignable display and control device in realtime using spatial alignment, and further action by the lumen traveling device as described above can be directed via the externally alignable display and control device.
- the alignment of the EADCD can optionally first be aligned with external markers (e.g., based on a fiducial sensor, etc.) and further aligned with the LTD (e.g., based on the LTD sensors) to retrieve data associated with the location of the LTD or the reference path.
- external markers e.g., based on a fiducial sensor, etc.
- LTD e.g., based on the LTD sensors
- the lumen traveling device is used to image, map, or provide treatment to a lumen that is a blood vessel or lymphatic duct.
- the lumen traveling device can be injected into a blood vessel and used to image the blood vessel for the presence of, e.g., plaque, stricture, or stenosis, and if necessary to provide treatment by delivering an expandable stent to the area.
- the lumen traveling device used to image a blood vessel for the presence of an embolism and deliver an agent for degrading the embolism.
- the lumen traveling device can be used to image a blood vessel for the presence of an aneurysm and if necessary provide treatment by delivering a clip or coil to the site.
- the lumen traveling device can be followed in the blood vessel by the externally alignable display and control device in real time.
- the lumen traveling device can be directed to advance or return to a site in the blood vessel by the externally alignable display and control device in real time, and further action by the lumen traveling device as described above can be directed via the externally alignable display and control device.
- a lumen traveling device is injected into a blood vessel in the lower extremity of a subject experiencing pain and poor healing in the limb.
- the externally alignable display and control device is used to direct the lumen traveling device into several branches of the blood vessel while displaying the results in real time until an area of stenosis is detected.
- the externally alignable display and control device is then used to direct the lumen traveling device to deploy an expandable stent utilizing extended appendages to expand the stent to fit the vessel.
- the externally alignable display and control device is then used to direct the lumen traveling device back to the site of entry by moving the externally alignable display and control device over the limb while viewing the progress of the lumen traveling device in real time, and the lumen traveling device is retrieved via a syringe.
- a lymphatic duct can be imaged or treated in the same manner as a blood vessel.
- inflammation e.g., associated with cancer or infection, etc.
- a lumen traveling device deployed in the lymph system or the vasculature can be monitored by a lumen traveling device deployed in the lymph system or the vasculature.
- the lumen traveling device and system is used to image, map, assist in diagnosis, sample, or provide treatment to a lumen that is part of a urinary tract.
- a lumen traveling device can be introduced into a urinary tract via the urethra (e.g., by catheter and/or locomotive aspects described herein) and used to image the urethra, bladder, ureters, and kidney ducts for the presence of, In an embodiment, tumors, strictures, bleeding, ulcers, stones, inflammation, infection, or the like.
- the lumen traveling device can be used to perform a treatment in a urinary tract such as disintegration of a stone, biopsy or removal of a tumor, directed killing of a microorganism or the like.
- the lumen traveling device is followed spatially in real time in the urinary tract by aligning the externally alignable display and control device.
- the lumen traveling device can be directed via the externally alignable display and control device in real time to advance (e.g., to ensure the entire bladder has been viewed) or to return to a previously viewed site in the bladder (e.g., by moving the externally alignable display and control device across the external abdomen), and further action by the lumen traveling device as described above can be directed via the externally alignable display and control device.
- a lumen traveling device can be introduced into a male reproductive system via the urethra (e.g. , by catheter and/or locomotive aspects described herein) to image or treat a site therein.
- the lumen traveling device is followed in the male reproductive system by the externally alignable display and control device in real time.
- the lumen traveling device can be directed spatially via the externally alignable display and control device in real time to advance or to return to a site, and further action by the lumen traveling device as described above can be directed via the externally alignable display and control device.
- a lumen traveling device is directed by the externally alignable display and control device to advance to a site in the vas deferens of a subject who has undergone a past vasectomy to evaluate the efficacy of the vasectomy procedure. If the vas deferens is not fully occluded, the lumen traveling device is directed to deliver a clip to completely block the lumen.
- a lumen traveling device can be introduced into a female reproductive system via the vagina (e.g., by direct delivery and/or locomotive aspects described herein) and used to image the vagina, cervix, uterus, and fallopian tubes for the presence of, for example, tumors, genital warts, strictures, tubal pregnancy, tubal ligation, abnormal bleeding, endometriosis, ulcers, inflammation, infection, or the like.
- the lumen traveling device can be used to perform a treatment in a reproductive tract such as ablation of tissue, biopsy or removal of a tumor, directed killing of a microorganism or the like.
- the lumen traveling device is followed in the reproductive tract by the externally alignable display and control device in real time.
- the lumen traveling device can be directed via the externally alignable display and control device in real time to advance (e.g., to ensure the entire uterus has been viewed) or to return to a previously viewed site in the reproductive tract, and further action by the lumen traveling device as described above can be directed via the externally alignable display and control device.
- the lumen traveling device is directed via the externally alignable display and control device to the fallopian tube to evaluate the presence of endometrial tissue occluding the fallopian tube and potentially preventing pregnancy. If occlusion is identified, the externally alignable display and control device is used to direct the lumen traveling device to emit thermal energy to ablate the tissue and open the tube.
- the externally alignable display and control device is then used to direct the lumen traveling device to the other fallopian tube by moving the externally alignable display and control device over the external abdomen while viewing the progress of the lumen traveling device in real time.
- the externally alignable display and control device includes at least one projector or display. In an embodiment, the externally alignable display and control device includes a projector configured to project at least one hologram (e.g., on the subject's body, on a surface, or into air).
- hologram e.g., on the subject's body, on a surface, or into air.
- the externally alignable display and control device includes a liquid crystal display (LCD), light-emitting diode display (LED), or a projection display.
- the EADCD includes an organic light emitting diode (OLED) or similar device that includes a sterile surface, and sufficient flexibility to function despite folds or creases.
- an organic light emitting diode includes an anode, cathode, OLED organic material, and a conductive layer.
- the OLED includes a double layer structure with separate hole transporting and electron-transporting layers, with light emission sandwiched in between the two layers.
- the EADCD includes multiple distinct display units forming one or more larger displays, with each display unit informed and controlled by the processor and controller, which may be indicating the sensed signals from the sensors.
- the EADCD may include a flexible backing, e.g., a rubber polymer, with discrete rigid display units (LCD, LED, or OLED, for example).
- information is displayed through multiple distinct display units (e.g., having LCD, LED, or OLED technology) combining to form an EADCD configured to provide displayed information; which information is displayed on which unit is determined optionally in real-time by the processor and controller using signals provided by sensors determining the location of the EADCD on the subject's body and the location of the lumen traveling device inside the subject's body, and optionally the location of each relative to the other.
- the EADCD is flexible, foldable, or otherwise able to be rearranged (e.g., a foldable OLED display).
- the EADCD includes at least one projector.
- a polymer light emitting diode can be utilized, since it emits light under an applied electric current.
- a PLED utilizes less energy than an OLED to produce the same level of luminescence.
- the PLED includes at least one of a derivative of poly(p-phenylene vinylene) and polyfluorene.
- the light comes from a single layer of electroluminescent polymer, which is held between two transparent elastic composite electrode layers.
- the EADCD includes a flexible or stretchable display including intrinsically stretchable OLEDs formed by elastic constituent materials, for example carbon nanotube (CNT)-polymer composite electrodes sandwiching an electroluminescent polymer blend layer or an elastic electroluminescent blend with an ultrathin gold coating on polydimethylsiloxane substrate and gallium- indium eutectic alloy liquid metal as the opposite electrode.
- the EADCD includes a flexible or stretchable display comprising intrinsically stretchable PLEDs including an electroluminescent polymer layer sandwiched between a pair of transparent elastomeric composite electrodes based on a thin silver nanowire (AgNW) network.
- AgNW silver nanowire
- the EADCD can provide real-time display of information by utilizing specific pixels of a flexible display and combining them to form a cohesive image, as controlled by the processor and controller and informed by sensors detecting the lumen traveling device, or at least one physiological characteristic of the subject.
- noncontiguous portions of a display may be utilized (e.g., light-emitting diodes emitting light) in such a manner as to complete an image.
- the EADCD includes an organic light emitting device (OLED).
- the EADCD includes a flexible organic light emitting diode (FOLED) that incorporates a flexible plastic substrate on which the electroluminescent organic semiconductor is deposited.
- the EADCD includes other illumination devices, such as silicon LEDs, LCD, electroluminescent devices, incandescent, or chemical devices.
- the EADCD includes a flexible electronic paper based display.
- the dynamic display includes a plastic flexible display with an organic thin film transistor (OTFT).
- OTFT organic thin film transistor
- the EADCD includes a dedicated device (e.g., a device held, for example, between the thumb and forefinger of the subject itself or a healthcare provider).
- the dedicated device is sized and shaped like a cell phone, or tablet.
- the EADCD includes a cell phone or tablet itself.
- the EADCD includes a user interface, and circuitry configured for running at least one computer program for monitoring the LTD.
- the dedicated device is sized and shaped to be worn on a hand (e.g., a device worn like a glove, watch, bracelet, badge, etc.).
- the dedicated device is sized and shaped to be worn on one or more fingers (e.g., a device worn as a ring).
- the EADCD includes at least one inertial sensor, accelerometer, proximity sensor, or landmark reader or fiducial reader (e.g., RFID, laser, etc.).
- the EADCD includes at least one topography sensor for detecting landmarks on a skin surface (e.g., an imaging sensor, optical sensor, etc.).
- the system further includes means to align the externally alignable display and control device with the path previously traveled by the lumen traveling device, including at least one of at least one inertial sensor, at least one fiducial sensor, at least one
- the topographical sensor includes at least one of an imaging sensor, or optical sensor.
- the at least one fiducial sensor includes at least one optical sensor, radiographic sensor, radiofrequency sensor, or magnetic sensor.
- the EADCD detects the topography of the skin area (e.g., by scanning the rough surface of the skin) as the lumen traveling device and system makes a first pass at imaging a site in the underlying lumen and records the results in memory, then on a subsequent pass, the EADCD scans the skin again and using comparison to the original scan identifies the site, then controls the LTD to the site.
- the EADCD uses triangulation between fiducials in the body (e.g., surgical staples) or on the body (e.g., placed on the skin at the beginning of the procedure) to align with a body site, then the EADCD controls the LTD to the corresponding site in the lumen.
- the LTD includes at least one wired or wireless connection between the one or more sensors (or sensor assemblies) and the EADCD, by way of a processor and/or controller.
- a processor and/or controller for example, in an
- the electronic circuitry receives information from the one or more sensors or sensor assemblies and determines if, for example, the LTD should change speed, direction, or release a tag or therapeutic agent, or take a biological sample of the lumen, and informs the controller.
- the processor can be programmed to select a particular location along the lumen to sample or treat by release of a therapeutic agent, or to tag for further analysis, or can be directed by the user (e.g., by a user interface), where the user includes the subject itself, a healthcare worker, a computer, or other user.
- the controller is configured to adjust the function of the LTD and/or EADCD including their function relative to each other.
- a processor can be configured to receive at least one signal from the one or more sensors or sensor assemblies regarding at least one of location of the LTD, the status of any biological sampling obtained or scheduled to be obtained, the release of any therapeutic agents or schedule of release based on what was put on board before the LTD began the lumen travel path.
- a system 100 includes a LTD 1 10 traveling through a lumen 130 (e.g. , intestinal tract), the LTD being sensed when the EADCD 120 is placed in planar proximity to the LTD that is located internal to the subject.
- the EADCD 120 and LTD 1 10 are able to cross-talk through the body surface of the subject when the EADCD is placed in planar proximity to the LTD, even though the LTD is located in a lumen 130 of the subject.
- the LTD is configured to transmit 140 (e.g. , RF transmission) through the lumen 130 surface and through the subject's skin 150, to the EADCD 120 that is external to the subject's body.
- the LTD 1 10 is able to transmit image data 170(e.g. , RF transmission) to the EADCD 120 through the skin 150 of the subject.
- the LTD 210 is configured to transmit 220 (e.g. , NIR transmission) images to the EADCD 230 in real time from a lumen.
- the real-time lumen image 240 is projected or otherwise displayed externally to the subject's body.
- the EADCD 270 is passed over a location of the subject's body that is marked 250 (e.g. by fiducials or sensors, including NIR location sensors, etc.) and is planar to the travel path of the LTD (including a historical travel path, the location of which is stored data), and the stored lumen image 260 is projected or otherwise displayed externally to the subject's body.
- the system 300 includes a LTD 310 that travels through a lumen by propelling itself with a paddle or rudder 340, and/or leg-like protrusions 330, which have optional suction cup bases 385 configured for biological sampling of the lumen wall 320.
- the LTD 310 is in wireless communication 380 with the EADCD 350 outside of the subject's body. Communications between the LTD 310 and EADCD 350 can occur through the skin 370 of the subject, when the EADCD 350 is aligned planar to the LTD 310 and can include contact with the outer surface 360 of the subject's skin.
- one or more biological sampling base 385 can be configured to sample at various depths of the lumen wall, including outward toward the skin 360 or inward toward the inner wall 390 of the lumen.
- a power source 395 is included in the LTD 310.
- at least one therapeutic agent compartment is contained in the LTD and configured for release of the at least one therapeutic agent as the LTD moves through the lumen.
- the release can be programmed to be at a specific location along the lumen, or at multiple scheduled time points or locations. In an embodiment, the release is gradually along at least part of the lumen traveling path.
- the therapeutic agent includes, but is not limited to, an anti- inflammatory agent, coagulant, anti-coagulant, anesthetic, analgesic, vitamin, mineral, chemotherapy agent, antibiotic, antimicrobial (e.g., antibiotic, antifungal, antiparasitic, or antiviral agent), vascular dilator, vascular constrictor, hormone, steroid, cytokine, chemokine, muscle relaxant, anti-spasmodic.
- At least one onboard instrument is contained in the LTD and configured for use as the LTD moves through the lumen or at a particular site along the lumen.
- the at least one onboard instrument includes, but is not limited to an imaging device, a biopsy tool, a deployment tool (e.g., for deploying a surgical clip or staple), a needle, or an energy emitter.
- a system 300 includes a LTD
- the LTD 310 moving in the direction of the arrow, through the lumen by contacting the inner walls of the lumen 320 with the various leg-like protrusions 330, some of which include caliper-like sampling devices 375 for biological sampling of the lumen.
- the caliper-like sampling devices 375 are configured to access the lumen wall 370 to the inner part of the subject's body 390 or outward toward the skin 360.
- the LTD 310 is in wireless
- the LTD 310 can take various forms and shapes without losing the character of the structure or function of the device as described herein, even though not all possible combinations are illustrated.
- a method, system, device, and/or computer program product relate to various embodiments disclosed herein.
- the processing circuit 400 is generally configured to accept input 402 from at least one sensor.
- the processing circuit 400 can be configured to receive configuration and reference data 412.
- Input 420 data can be accepted continuously or periodically.
- the processing circuit 400 analyzes data provided by one or more sensors, to determine the next action for the LTD, and instruct the controller (not shown). Based on the detected parameters as described herein, the processing circuit 400 may notify the controller (not shown). Based on the detected parameters as described herein, the processing circuit 400 may notify the
- the processing circuit 400 can also generate real-time or updated maps of the lumen in which it is traveling, or can instruct the LTD to stop, hover, attach to the lumen, change direction, release a therapeutic agent or tag, etc. In determining the analysis, the processing circuit 400 can make use of machine learning, artificial intelligence, interactions with databases (including reference data), pattern recognition, logging, intelligent control, fuzzy logic, neural networks, etc.
- the processing circuit 400 includes a processor 406, which can be a specific use computer in certain instances.
- the processor 406 is part of a general use computer.
- an application of specific integrated circuit (ASIC), one or more field programmable gate arrays (FPGAs), digital-signal-processor (DSP), group processing is included.
- the processing circuit 400 includes memory 408.
- memory 408 is one or more devices (e.g. , RAM, ROM, Flash memory, hard disk storage, etc.) for storing data and/or computer code for facilitating the various processes described herein. Memory 408 may be included as non-transient volatile memory or non-volatile memory.
- memory 408 includes at least one of database components, object code components, script components, or other information structure for supporting the various activities and information structures described herein.
- memory 408 can be communicably connected to the processor 406 and can include computer code or instructions to the controller (not shown) for executing the processes described herein.
- the memory 408 includes memory buffer 410 configured to receive data from one or more sensors via input 402, and includes, for example, a real-time data stream from one or more sensors.
- the data received via the input 402 can be stored in memory buffer 410 until it is accessed by various modules of the memory 408, including a sensor module 414 or feedback module 416.
- the memory 408 includes
- configuration data 418 can include, for example, information related to engaging with other components (e.g., sensors of the system, the LTD itself, the EADCD, etc.) and can include a command set for interfacing with a computer system used to transfer user settings or otherwise set up the system (e.g., graphical user interface controls, menus, visual information, etc.).
- the configuration data 418 can include a command set needed to interface with communication components (e.g., a universal serial bus (USB) interface, Wi-Fi interface, Ethernet, etc.).
- the processing circuit 400 can format data for output 404 to allow a user to configure the system as described herein.
- the processing circuit 400 can also generate commands needed to generate visual or audio warnings for display on the EADCD, or a speaker thereof. In an embodiment, the processing circuit 400 also generates commands needed to drive haptic or other mechanical feedback (e.g., vibration).
- the configuration data 418 can include information as to how often input should be accepted from a sensor or determine the default values required to initiate communication with sensors or other components of the processing circuit 400 or other systems described herein.
- the processing circuit 400 further includes output 404 configured to provide output to the EADCD or another output device, or components of the system as described herein.
- the feedback module 416 generates feedback to produce output via a feedback device (e.g., EADCD), including output as information to a display, audio speaker, haptic response, or network signal.
- a feedback device e.g., EADCD
- a non- transitory computer-readable medium having instructions stored thereon, the instructions forming a program executable by a processing circuit to instruct the LTD of a next action as disclosed herein.
- the system 500 includes a lumen traveling device 510 is able to transmit image data 570(e.g., RF transmission) to the EADCD 530, 580 as part of a glove 520 or ring 580 through the skin 550 of the subject.
- the EADCD includes a display 540 of transmitted data 570 from the lumen traveling device 510.
- a lumen imaging system is used to visualize and localize intestinal lesions, polyps, and tumors in real time.
- a lumen imaging system includes a camera-bearing lumen traveling device (LTD) and a handheld externally alignable display and control device (EADCD).
- the EADCD functions like a computer interface having input (e.g., computer mouse or graphic interface) and output (e.g. , display) capabilities.
- Intraluminal images, transmitted by the LTD are received and displayed by the handheld externally alignable display and control device in real time, but only when the EADCD is aligned directly over the LTD.
- Real time display of images transmitted by the LTD from an intraluminal location provides immediate feedback for a physician, while wireless input functions allow the physician to use the EADCD to direct the LTD to areas of interest or to reexamine selected areas of the intestine.
- the lumen imaging system allows control of the LTD using the EADCD in a way that is analogous to control of a screen cursor by a computer mouse. Additionally, input capabilities on the EADCD, including a graphical interface and touch screen, permit two-way communication with the LTD as well as access to internal storage for retrieval of images previously obtained at specific locations
- the LTD which is an ingestible capsule approximately 1 1 mm by 26, mm includes cameras, light sources, transmitters, receivers, control circuitry, memory, location sensors, a battery, and a means of locomotion to move within the gastrointestinal tract.
- the cameras, located at each end of the LTD, include a complementary metal oxide semiconductor (CMOS) image sensor and an adjustable lens. Each lens is surrounded by light emitting diodes (LEDs) to illuminate the intestinal wall.
- CMOS complementary metal oxide semiconductor
- LEDs light emitting diodes
- a micro-camera with a 0.6 mm color lens with magnetic coils for focus adjustment, a CMOS image sensor, and 4 white LEDs can be adapted for use with the instant embodiment.
- Application-specific integrated circuitry is designed to process and transmit image data, and to receive and act on command signals from the display device.
- a transceiver chip capable of transmitting image data at 20 Mbps on a 500 MHz RF channel has been used with locating devices in the gastrointestinal system of patients, and can be adapted for use with this embodiment described herein.
- Control circuitry to actuate the cameras, the location sensors, and the locomotion system is included with memory to allow programming of the LTD.
- Sensors are incorporated in the LTD to identify the location of the device.
- image analyzers are used to identify intestinal locations (e.g., duodenum, ileocecal valve, cecum), or lesions, polyps, tumors or inflammation sites, and record the locations in memory.
- Additional location sensors may include a pH sensor that determines pH in the intestine or a time-keeping device that records the elapsed time of transit for the LTD.
- Intraluminal images transmitted in real time to the display device are informationally linked to the coincident location identifiers. For example, serial images of inflammation in the small intestine are coded so as to be linked to the corresponding elapsed times of transit for the LTD.
- Momentary display of interesting intestinal images e.g., images showing inflammation of the small intestine
- EADCD for location identifiers e.g., elapsed transit time, image analyses, and pH results
- location identifiers e.g., elapsed transit time, image analyses, and pH results
- the EADCD is used to control movement of the LTD in the region of the intestine.
- the LTD has a locomotion system and position control circuitry that responds to signals from the EADCD.
- the locomotion system includes
- a device with jointed legs that is mobile in tubes and channels containing bends and obstructions can be adapted for use with the instant embodiment in a lumen of a patient.
- capsule endoscopic devices with multiple legs for use in a digestive system have been described and can be adapted for use with the instant embodiment in a lumen of a patient.
- the articulated legs are moved by leg controls that include circuitry and motors to actuate the legs in response to signals from the physician (or system operator) that are relayed by the display device.
- Motion control circuitry connecting sensors and locomotion mechanisms for micro-robots can be adapted for use with the instant embodiment. Movements and associated images captured by the LTD are informationally linked to their location in the intestine as identified by image recognition (intestinal landmarks), pH, time of travel, or other location identifiers. Movement of the LTD is controlled by a physician/operator using the EADCD. Real time imaging informs the operator as to which direction to move the LTD, and movement of the EADCD sends signals to actuate the articulated legs on the LTD. Further external systems to control the motion of capsule endoscopes can be adapted for use with the instant embodiment.
- the externally alignable display and control device receives images transmitted by the LTD.
- Image data transmitted at radio frequencies is received by transceivers in the display device, but the signal is filtered to only allow receipt of transmissions emanating from immediately under the EADCD (see Fig. 1 A-C).
- Computational methods to filter signals and localize medical devices in the digestive tract can be adapted for various embodiments described herein.
- location-dependent signal parameters including: angle of arrival, time of arrival and received signal strength are used to estimate the location of a transmitting device and may be used to filter the signals received from the LTD.
- images will be displayed by the EADCD only when the EADCD is directly over the LTD.
- the image data and corresponding location data is stored in memory on the LTD until the LTD passes out of the intestinal tract of the patient.
- temperature sensor in the LTD monitors the ambient temperature and signals a control circuit when the temperature falls below body temperature after the LTD exits the anus.
- the control circuit provides current to the memory units on the device, erasing any imaging, location and patient identification data.
- Temperature controls for computer memory comprising temperature sensors and resistors have been described and can be adapted for use with the instant embodiment.
- intraluminal images is used to monitor lung cancer.
- An intraluminal imaging system includes a lumen traveling device (LTD) and an externally alignable display and control device (EADCD) capable of recalling images obtained at specific lumen locations.
- LTD lumen traveling device
- EADCD externally alignable display and control device
- To monitor lung cancer initial intraluminal images of lung cancer tumors are obtained with a LTD introduced into the bronchial tree by inhalation or bronchial scope. Images of any tumors and their locations in the airway are transmitted to the EADCD and stored in memory.
- the LTD is reintroduced in the airway, and the system is used to repeat imaging of the tumor locations. The current images are compared to the pre-chemotherapy images.
- the LTD locomotion system and real time image display and location sensing are used to guide movement of the lumen traveling device using a handheld EADCD.
- the LTD is fabricated from biodegradable components, such as silk or paper.
- the lifespan of the device can be altered based on the crystalline structure of the silk, which dictates the rate at which water accesses the silk structure and degrades it. In this way, the device can be designed for a lifespan of minutes, days, months, or even years.
- magnesium or silicone can also be utilized, based on the specific design parameters desired for a biodegradable device.
- a patient with suspected lung cancer nodules is imaged with a lumen imaging system using a LTD introduced into the airway and an EADCD to display the localized images in real time and to control the movement of the LTD.
- the capsular LTD is approximately 7 mm in diameter and 23 mm in length and includes: a camera, a light source, transmitters, receivers, control circuitry, memory, location sensors, a battery, and a means of locomotion.
- a high resolution camera responsive to external signals, includes a CMOS image sensor, an adjustable lens and circuitry to process and transmit image data in real time.
- CMOS image sensor an adjustable lens and circuitry to process and transmit image data in real time.
- a micro-camera with a 0.6 mm color lens with magnetic coils for focus adjustment a CMOS image sensor, and 4 white LEDs can be adapted for specific embodiments.
- imaging devices, high performance electronics, and radio frequency electronics formed from bioresorbable materials can be adapted for various embodiments. Intraluminal images transmitted by the LTD are only received and transmitted by the EADCD when the EADCD is immediately over the LTD. See Fig. 1.
- location-dependent signal parameters including: angle of arrival, time of arrival and received signal strength are used to estimate the location of a transmitting device and may be used to filter the signals received from the LTD.
- Image data transmitted from the airway by the LTD are received by the EADCD and stored in memory along with linked location sensing data.
- the EADCD is a handheld device (e.g. , smart phone) with transceivers, display capability and location sensors to display intraluminal images in real time and remember their location in the body.
- Image data transmitted at radio frequencies is received by transceivers in the EADCD, but the signals are filtered to only allow receipt of transmissions emanating from immediately under the EADCD (see Fig. 1 C).
- Computational methods to filter signals and localize medical devices in the digestive tract are described and can be adapted for use with the instant embodiment.
- location-dependent signal parameters including angle of arrival, time of arrival and received signal strength are used to estimate the location of a transmitting device, and may be used to filter the signals received from the LTD.
- images will be displayed by the EADCD only when the EADCD is directly over the LTD.
- the EADCD has location sensors to identify body locations at the time images are displayed.
- the EADCD may have near infrared (NIR) sensors to detect landmark subsurface features in the lungs, such as vasculature patterns, or patterns of blood within vasculature that act as markers to identify a location in the lung. See Fig. 2A.
- NIR near infrared
- Methods and systems to obtain and store landmark features can be adapted for use with the instant embodiment, for example images of landmark features (location identifiers) are linked to simultaneously transmitted intraluminal images from the LTD.
- Registration circuitry on the EADCD identifies landmark features previously stored in memory and recalls the linked intraluminal images.
- passing the handheld EADCD over the location of a lung tumor previously imaged with a LTD will recall the LTD image linked to the landmark feature (e.g., vascular pattern at the tumor site). See Fig. 2B.
- Multiple intraluminal airway images and their associated landmarks may be accessed by moving the EADCD with NIR sensors across the body surface.
- initial intraluminal images may be compared to images obtained at a later time.
- intraluminal imaging with a LTD is done before and after treatment of a lung tumor with chemotherapy. Revisiting the same sites in the airway is guided by the stored landmark features. Registration of the EADCD and the LTD with the landmark features at the tumor site allows comparison of the images obtained before and after chemotherapy.
- the EADCD directs a magnetic field to move and position the LTD within the airway lumen.
- the LTD contains magnetic components which are responsive to an externally applied magnetic field. If the device is designed to be biodegradable, detachable magnetic iron filings or legs can be included. In an embodiment, the iron filings are coated in silicone and the entirety is biodegradable. In an embodiment, the detachable magnetic components are not biodegradable but are retrievable by a magnet or endoscope, or are naturally expelled by cough once the remainder of the device has biodegraded.
- the EADCD may direct varying magnetic fields to move the LTD.
- magnetic steering and positioning systems for intraluminal capsules are described and can be adapted for use in the instant embodiment.
- circuitry and location sensors in the EADCD apply variable magnetic fields to steer the LTD within the airway by movement of the EADCD.
- the EADCD is moved laterally at a bronchial junction to steer the LTD down the lumen of the branch.
- Steering of the LTD is guided by real time display of intra-bronchial images by the EADCD.
- Repeat imaging of the bronchial tree to reexamine tumors following chemotherapy may be guided by the landmark images stored in memory in the EADCD.
- the landmark images (vasculature patterns from NIR sensing) at the tumor site may be recalled from EADCD memory.
- the stored intraluminal images previously transmitted by the LTD may be searched for images of the tumor and the corresponding linked landmarks (NIR patterns of subsurface vasculature) obtained by the EADCD are used to identify the tumor location.
- the EADCD is moved over the body surface until the landmark pattern is located and the EADCD alerts the physician, caregiver, patient or other operator.
- the LTD is guided to the tumor site as the EADCD is moved over the body surface and displays the tumor site in real time once the location is reached. Comparison of images obtained before and after chemotherapy may indicate the status of the tumor, i.e., stable, shrinking, or growing. Removal of the LTD from the airway is accomplished by applying a variable magnetic field and moving the EADCD up the bronchial tube to the trachea.
- the LTD may be expelled by cough or retrieved with a bronchoscope, if the device is not biodegradable.
- the lumen imaging system may be used to image putative tumor nodules ranging in size from 9-20 mm diameter (based on computed tomography (CT) scans) in order to evaluate the nodules.
- CT computed tomography
- the patient is given a LTD to inhale, which is programmed to transmit data to an EADCD only upon arrival at a nodule site.
- Location sensors on the LTD signal arrival at a nodule site and alert the operator to move the EADCD over the LTD to allow image data transmission.
- the LTD is moved proximal to the next nodule on the CT scan and instructed to locate the nodule site using a location identifier ⁇ e.g. , image analysis).
- each nodule site is found by the LTD using location identifiers and the corresponding landmark vascular pattern is imaged by the EADCD.
- Limited transmissions by the LTD conserve its battery and stored location identifiers (e.g. , intraluminal images) and subsurface landmarks (e.g. , vasculature patterns) allow returns to each of the nodules.
- the stored nodule images are analyzed to determine malignancy, growth status and spread of putative tumor nodules.
- an implementer may opt for a mainly hardware and/or firmware vehicle; alternatively, if flexibility is paramount, the implementer may opt for a mainly software implementation; or, yet again alternatively, the implementer may opt for some combination of hardware, software, and/or firmware.
- any vehicle to be utilized is a choice dependent upon the context in which the vehicle will be deployed and the specific concerns (e.g. , speed, flexibility, or predictability) of the implementer, any of which may vary.
- Those skilled in the art will recognize that optical aspects of implementations will typically employ optically-oriented hardware, software, and or firmware. In some implementations described herein, logic and similar
- implementations can include software or other control structures. Electronic circuitry, for example, may have one or more paths of electrical current constructed and arranged to implement various functions as described herein.
- one or more media can be configured to bear a device- detectable implementation when such media hold or transmit device detectable instructions operable to perform as described herein.
- implementations can include an update or modification of existing software or firmware, or of gate arrays or programmable hardware, such as by performing a reception of or a transmission of one or more instructions in relation to one or more operations described herein.
- an implementation can include special-purpose hardware, software, firmware components, and/or general-purpose components executing or otherwise invoking special-purpose components. Specifications or other implementations can be transmitted by one or more instances of tangible transmission media as described herein, optionally by packet transmission or otherwise by passing through distributed media at various times.
- implementations may include executing a special-purpose instruction sequence or otherwise invoking circuitry for enabling, triggering, coordinating, requesting, or otherwise causing one or more
- operational or other logical descriptions herein may be expressed directly as source code and compiled or otherwise invoked as an executable instruction sequence.
- C++ or other code sequences can be compiled directly or otherwise implemented in high-level descriptor languages (e.g. , a logic-synthesizable language, a hardware description language, a hardware design simulation, and/or other such similar mode(s) of expression).
- high-level descriptor languages e.g. , a logic-synthesizable language, a hardware description language, a hardware design simulation, and/or other such similar mode(s) of expression.
- some or all of the logical expression may be manifested as a Verilog-type hardware description or other circuitry model before physical implementation in hardware, especially for basic operations or timing- critical applications.
- electro-mechanical system includes, but is not limited to, electrical circuitry operably coupled with a transducer (e.g.
- an actuator e.g. , an actuator, a motor, a piezoelectric crystal, a Micro Electro Mechanical System (MEMS), etc.
- electrical circuitry having at least one discrete electrical circuit, electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g. , a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein), electrical circuitry forming a memory device (e.g. , forms of memory (e.g.
- a communications device e.g. , a modem, communications switch, optical-electrical equipment, etc.
- any non-electrical analog thereto such as optical or other analogs.
- electro-mechanical systems include but are not limited to a variety of consumer electronics systems, medical devices, as well as other systems such as motorized transport systems, factory automation systems, security systems, and/or communication/computing systems. Electro-mechanical as used herein is not necessarily limited to a system that has both electrical and mechanical actuation except as context may dictate otherwise.
- electrical circuitry includes, but is not limited to, electrical circuitry having at least one discrete electrical circuit, electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g.
- a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein
- electrical circuitry forming a memory device e.g. , forms of memory (e.g. , random access, flash, read only, etc.)
- electrical circuitry forming a communications device e.g. , a modem, communications switch, optical-electrical equipment, etc.
- any two components so associated can also be viewed as being “operably connected,” or “operably coupled,” to each other to achieve the desired functionality, and any two components capable of being so associated can also be viewed as being “operably couplable,” to each other to achieve the desired functionality.
- operably couplable include but are not limited to physically mateable and/or physically interacting components, and/or wirelessly interactable, and/or wirelessly interacting components, and/or logically interacting, and/or logically interactable components.
- one or more components can be referred to herein as “configured to,” “configured by,” “configurable to,” “operable/operative to,”
- a system having at least one of A, B, and C would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.).
- a convention analogous to "at least one of A, B, or C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g. , "a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.).
- any tangible, non-transitory computer-readable storage medium may be utilized, including magnetic storage devices (hard disks, floppy disks, and the like), optical storage devices (CD-ROMs, DVDs, Blu-ray discs, and the like), flash memory, and/or the like.
- These computer program instructions may be loaded onto a general purpose computer, special purpose computer, or other programmable data processing apparatus to produce a machine, such that the instructions that execute on the computer or other programmable data processing apparatus create a means for implementing the functions specified.
- These computer program instructions may also be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture, including implementing means that implement the function specified.
- the computer program instructions may also be loaded onto a computer or other programmable data processing apparatus to cause a series of operational steps to be performed on the computer or other programmable apparatus to produce a computer-implemented process, such that the instructions that execute on the computer or other programmable apparatus provide steps for implementing the functions specified.
- the terms "comprises,” “comprising,” and any other variation thereof are intended to cover a non-exclusive inclusion, such that a process, a method, an article, or an apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, system, article, or apparatus.
- the system is integrated in such a manner that the system operates as a unique system configured specifically for function of one or more of the systems described herein (e.g. , with a described lumen traveling device, etc.), and any associated computing devices of the system operate as specific use computers for purposes of the claimed system, and not general use
- At least one associated computing device of the system operates as a specific use computer for purposes of the claimed system, and not a general use computer.
- at least one of the associated computing devices of the system is hardwired with a specific ROM to instruct the at least one computing device.
- the systems described herein e.g. , with a described lumen traveling device, etc.
- associated systems/devices effect an improvement at least in the technological field of lumen traveling devices.
- Various embodiments described herein contribute to the medical field, specifically with diagnosis and/or treatment of disease, or maintenance of a healthy state by allowing visualization of internal locations within a subject that are not otherwise as easily accessible.
- a unique computer and/or system are required.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Optics & Photonics (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Signal Processing (AREA)
- Physiology (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Endoscopes (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/926,202 US20170119236A1 (en) | 2015-10-29 | 2015-10-29 | Lumen traveling device |
US14/926,158 US20170119235A1 (en) | 2015-10-29 | 2015-10-29 | Lumen traveling device |
US14/926,233 US20170119278A1 (en) | 2015-10-29 | 2015-10-29 | Lumen traveling device |
PCT/US2016/058796 WO2017075009A1 (en) | 2015-10-29 | 2016-10-26 | Lumen traveling device |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3367875A1 true EP3367875A1 (en) | 2018-09-05 |
Family
ID=58630850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16860658.0A Withdrawn EP3367875A1 (en) | 2015-10-29 | 2016-10-26 | Lumen traveling device |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3367875A1 (en) |
CN (1) | CN108366718A (en) |
HK (1) | HK1259003A1 (en) |
WO (1) | WO2017075009A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019076698A1 (en) * | 2017-10-19 | 2019-04-25 | Koninklijke Philips N.V. | Handheld medical interface for intraluminal device and associated devices, systems, and methods |
WO2019173283A1 (en) | 2018-03-05 | 2019-09-12 | Marquette University | Method and apparatus for non-invasive hemoglobin level prediction |
US20210267438A1 (en) * | 2018-06-29 | 2021-09-02 | Miraki Innovation Think Tank, Llc | Miniaturized intra-body controllable medical device employing machine learning and artificial intelligence |
CN109875483B (en) * | 2019-01-25 | 2021-11-16 | 合肥市树果药业有限公司 | Self-propelled capsule type gastroscope |
WO2020178819A1 (en) * | 2019-03-04 | 2020-09-10 | Photopill Medical Ltd. | Method and device for gut microbiota manipulation |
CN111839468B (en) * | 2020-08-18 | 2024-09-10 | 重庆金山医疗技术研究院有限公司 | PH capsule operating means and detecting instrument |
CN115029223B (en) * | 2022-04-28 | 2023-05-02 | 江南大学 | Soft sampling robot and operation method |
CN119222433A (en) * | 2024-12-04 | 2024-12-31 | 中国海洋大学 | A driving-sensing integrated pipeline inspection software robot |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6240312B1 (en) * | 1997-10-23 | 2001-05-29 | Robert R. Alfano | Remote-controllable, micro-scale device for use in in vivo medical diagnosis and/or treatment |
US7039453B2 (en) * | 2000-02-08 | 2006-05-02 | Tarun Mullick | Miniature ingestible capsule |
IL154391A (en) * | 2002-02-11 | 2009-05-04 | Given Imaging Ltd | Self propelled device |
US20040254455A1 (en) * | 2002-05-15 | 2004-12-16 | Iddan Gavriel J. | Magneic switch for use in a system that includes an in-vivo device, and method of use thereof |
JP2004041709A (en) * | 2002-05-16 | 2004-02-12 | Olympus Corp | Capsule medical care device |
JP2004350963A (en) * | 2003-05-29 | 2004-12-16 | Olympus Corp | Capsule type medical treatment apparatus |
EP2268261B1 (en) * | 2008-03-05 | 2017-05-10 | Proteus Digital Health, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US20110245604A1 (en) * | 2010-03-30 | 2011-10-06 | Chuen-Tai Yeh | Capsule endoscope and capsule endoscopy system |
EP2617346B1 (en) * | 2011-05-30 | 2017-09-06 | Olympus Corporation | Antenna device, antenna and antenna holder |
AU2012322673A1 (en) * | 2011-10-11 | 2014-05-29 | Senseonics, Incorporated | Electrodynamic field strength triggering system |
TWI520708B (en) * | 2013-09-26 | 2016-02-11 | 連吉時 | Magnetic control system for capsule endoscope |
-
2016
- 2016-10-26 WO PCT/US2016/058796 patent/WO2017075009A1/en active Application Filing
- 2016-10-26 CN CN201680072745.6A patent/CN108366718A/en not_active Withdrawn
- 2016-10-26 EP EP16860658.0A patent/EP3367875A1/en not_active Withdrawn
-
2019
- 2019-01-29 HK HK19101490.2A patent/HK1259003A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2017075009A1 (en) | 2017-05-04 |
HK1259003A1 (en) | 2019-11-22 |
CN108366718A (en) | 2018-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20170119235A1 (en) | Lumen traveling device | |
EP3367875A1 (en) | Lumen traveling device | |
US20170119278A1 (en) | Lumen traveling device | |
US20170119236A1 (en) | Lumen traveling device | |
US20220313375A1 (en) | Systems and methods for robotic bronchoscopy | |
US10271764B2 (en) | Intraluminal devices with deployable elements | |
Chen et al. | Magnetically actuated capsule robots: A review | |
Valdastri et al. | Advanced technologies for gastrointestinal endoscopy | |
Shamsudhin et al. | Magnetically guided capsule endoscopy | |
Ciuti et al. | Capsule endoscopy: from current achievements to open challenges | |
US8066632B2 (en) | Teleoperated endoscopic capsule equipped with active locomotion system | |
JP4137740B2 (en) | Capsule type medical device and capsule type medical device guidance system | |
US20220218303A1 (en) | Ultrasonic Capsule Endoscopy Device having Image-based Relative Motion Estimation | |
Leung et al. | A therapeutic wireless capsule for treatment of gastrointestinal haemorrhage by balloon tamponade effect | |
US20210060296A1 (en) | Miniaturized intra-body controllable medical device | |
US11950868B2 (en) | Systems and methods for self-alignment and adjustment of robotic endoscope | |
Goffredo et al. | Swallowable smart pills for local drug delivery: present status and future perspectives | |
Menciassi et al. | Future developments of video capsule endoscopy: Hardware | |
US9693676B2 (en) | Toroidal balloon-driven vehicle | |
US10194832B2 (en) | Systems and methods for modular intraluminal device power transfer | |
US10188316B2 (en) | Systems and methods for modular intraluminal device power transfer | |
JP4129269B2 (en) | Capsule medical device | |
Gorlewicz et al. | Mesoscale mobile robots for gastrointestinal minimally invasive surgery (mis) | |
Xu et al. | Design of Capsule Robot for Magnetic Gastric Biopsy and Drug Administration | |
Valdastri | Mesoscale mobile robots for gastrointestinal minimally invasive surgery (mis) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180529 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20190410 |